177 related articles for article (PubMed ID: 22926618)
1. Serotonin-norepinephrine reuptake inhibitor treatment for tinnitus and depression.
Chang JP; Wu CC
J Clin Psychopharmacol; 2012 Oct; 32(5):729. PubMed ID: 22926618
[No Abstract] [Full Text] [Related]
2. Duloxetine treatment of social anxiety disorder with comorbid major depression.
Lin CC
J Clin Psychopharmacol; 2008 Oct; 28(5):591-2; author reply 592-3. PubMed ID: 18794669
[No Abstract] [Full Text] [Related]
3. Biological perspectives. Serotonin and norepinephrine reuptake inhibitors (SNRIs): venlafaxine and duloxetine.
Lee SI; Keltner NL
Perspect Psychiatr Care; 2006 May; 42(2):144-8. PubMed ID: 16677140
[No Abstract] [Full Text] [Related]
4. Duloxetine-modulating effects of brain structure in major depressive disorder with panic disorder.
Lai CH
J Clin Psychopharmacol; 2010 Feb; 30(1):88-9. PubMed ID: 20075662
[No Abstract] [Full Text] [Related]
5. [Physical recovery is part of remission].
Krankenpfl J; 2004; 42(3-4):110. PubMed ID: 15311907
[No Abstract] [Full Text] [Related]
6. A pragmatic 12-week, randomized trial of duloxetine versus generic selective serotonin-reuptake inhibitors in the treatment of adult outpatients in a moderate-to-severe depressive episode.
Martinez JM; Katon W; Greist JH; Kroenke K; Thase ME; Meyers AL; Edwards SE; Marangell LB; Shoemaker S; Swindle R
Int Clin Psychopharmacol; 2012 Jan; 27(1):17-26. PubMed ID: 22027844
[TBL] [Abstract][Full Text] [Related]
7. Duloxetine-induced cutaneous adverse reaction.
Oulis P; Masdrakis VG; Karakatsanis NA; Karapoulios E; Kouzoupis AV; Soldatos CR
J Clin Psychopharmacol; 2008 Feb; 28(1):104-5. PubMed ID: 18204353
[No Abstract] [Full Text] [Related]
8. Successful duloxetine use to prevent venlafaxine withdrawal symptoms.
Hsiao MC; Liu CY
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):576. PubMed ID: 17889418
[No Abstract] [Full Text] [Related]
9. Digging for data on harms in duloxetine trials.
Doshi P; Zito J; dosReis S
BMJ; 2014 Jun; 348():g3578. PubMed ID: 24904123
[No Abstract] [Full Text] [Related]
10. Burning paresthesia related to duloxetine therapy.
Woo YS; Bahk WM
J Clin Psychopharmacol; 2014 Jun; 34(3):392-4. PubMed ID: 24633002
[No Abstract] [Full Text] [Related]
11. Manic switching in patients receiving duloxetine.
de Dios C; Ezquiaga E
Am J Psychiatry; 2007 Jul; 164(7):1121. PubMed ID: 17606669
[No Abstract] [Full Text] [Related]
12. Combining mirtazapine and duloxetine in treatment-resistant depression improves outcomes and sexual function.
Ravindran LN; Eisfeld BS; Kennedy SH
J Clin Psychopharmacol; 2008 Feb; 28(1):107-8. PubMed ID: 18204355
[No Abstract] [Full Text] [Related]
13. Efficacy and tolerability of duloxetine, a novel dual reuptake inhibitor, in the treatment of major depressive disorder.
Schatzberg AF
J Clin Psychiatry; 2003; 64 Suppl 13():30-7. PubMed ID: 14552654
[TBL] [Abstract][Full Text] [Related]
14. Is there a place for duloxetine?
Drug Ther Bull; 2007 Apr; 45(4):29-32. PubMed ID: 17451072
[TBL] [Abstract][Full Text] [Related]
15. Safety and tolerability of duloxetine in elderly patients with major depressive disorder: a pooled analysis of two placebo-controlled studies.
Oakes TM; Katona C; Liu P; Robinson M; Raskin J; Greist JH
Int Clin Psychopharmacol; 2013 Jan; 28(1):1-11. PubMed ID: 23138680
[TBL] [Abstract][Full Text] [Related]
16. Duloxetine: a new serotonin/noradrenaline reuptake inhibitor for the treatment of depression.
Rabasseda X
Drugs Today (Barc); 2004 Sep; 40(9):773-90. PubMed ID: 15538550
[TBL] [Abstract][Full Text] [Related]
17. Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial.
Goldstein DJ; Mallinckrodt C; Lu Y; Demitrack MA
J Clin Psychiatry; 2002 Mar; 63(3):225-31. PubMed ID: 11926722
[TBL] [Abstract][Full Text] [Related]
18. Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on attention and executive functions in patients with major depressive disorder.
Herrera-Guzmán I; Herrera-Abarca JE; Gudayol-Ferré E; Herrera-Guzmán D; Gómez-Carbajal L; Peña-Olvira M; Villuendas-González E; Joan GO
Psychiatry Res; 2010 May; 177(3):323-9. PubMed ID: 20385412
[TBL] [Abstract][Full Text] [Related]
19. Clinical impact of duloxetine treatment on sleep in patients with major depressive disorder.
Brecht S; Kajdasz D; Ball S; Thase ME
Int Clin Psychopharmacol; 2008 Nov; 23(6):317-24. PubMed ID: 18854719
[TBL] [Abstract][Full Text] [Related]
20. False conclusions regarding duloxetine's purported efficacy in pain among depressed patients.
Spielmans GI
Psychiatr Danub; 2010 Dec; 22(4):550; author reply 551. PubMed ID: 21169898
[No Abstract] [Full Text] [Related]
[Next] [New Search]
